The vaccines against COVID – 19, developed by the Chinese laboratories CanSino Biologics and Sinovac were approved by the Federal Commission for the Protection against Sanitary Risks of Mexico (Cofepris) for emergency use in people of 18 years or more.
Hugo López-Gatell, Undersecretary of Prevention and Health Promotion explained that these vaccines have shown low efficacy compared to others, however, as more data accumulates and with the advancement of information it is possible that this changes and there is a higher estimate.
Mexico is one of the countries where the Cansino vaccine is being tested. The 30 of October, the first doses of this vaccine arrived to carry out phase three of clinical trials in the country. The federal government plans to buy CanSino 35 millions of doses.
The vaccine was approved for use in the Chinese military last year past and since then it has been administered to at least 50 thousand people. Last Friday, both Chinese companies submitted their application to the regulatory health agency.
With the approval of these two vaccines, Mexico now has five authorized biologics: Pfizer, AstraZeneca , Sinovac, CanSino and Sputnik.
Continue Reading: San Luis Potosí health authorities detect a new Mexican variant of coronavirus
